2021
DOI: 10.1021/acsmedchemlett.1c00279
|View full text |Cite
|
Sign up to set email alerts
|

RNA: Opening New Doors in Medicinal Chemistry, a Special Issue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“… 36 It has been recently pointed out that several therapies based on small molecules or oligonucleotides present the general aim of targeting RNA biology. 37 RNase A has been also frequently used as a model protein in metalation studies, and structures with several metallodrugs, 38 , 39 including cisplatin, carboplatin, oxaliplatin, 40 and Ru-, 41 Rh-, 42 Pd-, 43 Ir-, 44 and Au-based drugs, 45 are known. Recently, the metalation of arsenoplatin-1, a dual pharmacophore anticancer agent, has been presented.…”
Section: Introductionmentioning
confidence: 99%
“… 36 It has been recently pointed out that several therapies based on small molecules or oligonucleotides present the general aim of targeting RNA biology. 37 RNase A has been also frequently used as a model protein in metalation studies, and structures with several metallodrugs, 38 , 39 including cisplatin, carboplatin, oxaliplatin, 40 and Ru-, 41 Rh-, 42 Pd-, 43 Ir-, 44 and Au-based drugs, 45 are known. Recently, the metalation of arsenoplatin-1, a dual pharmacophore anticancer agent, has been presented.…”
Section: Introductionmentioning
confidence: 99%
“…Also, the discovery of riboswitch targeting drug-like molecule (ribocil) with antibacterial activity against bacteria harboring the FMN riboswitch provides further support that identifying RNA-targeting some molecules is a viable drug development strategy. 6 Further, the identification of antifungal molecules (by Pyle and coworkers) that target the highly structured group II intron and inhibit splicing, 7 along with other recent discoveries, [8][9][10][11][12] provides additional validation of the viability of RNAs, particularly highly structured RNAs, as drug targets.…”
Section: Introductionmentioning
confidence: 99%